1 Introduction to Research & Analysis Reports
1.1 Pharma Grade Lentinan Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Pharma Grade Lentinan Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Pharma Grade Lentinan Overall Market Size
2.1 Global Pharma Grade Lentinan Market Size: 2022 VS 2029
2.2 Global Pharma Grade Lentinan Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Pharma Grade Lentinan Sales: 2018-2029
3 Company Landscape
3.1 Top Pharma Grade Lentinan Players in Global Market
3.2 Top Global Pharma Grade Lentinan Companies Ranked by Revenue
3.3 Global Pharma Grade Lentinan Revenue by Companies
3.4 Global Pharma Grade Lentinan Sales by Companies
3.5 Global Pharma Grade Lentinan Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Pharma Grade Lentinan Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Pharma Grade Lentinan Product Type
3.8 Tier 1, Tier 2 and Tier 3 Pharma Grade Lentinan Players in Global Market
3.8.1 List of Global Tier 1 Pharma Grade Lentinan Companies
3.8.2 List of Global Tier 2 and Tier 3 Pharma Grade Lentinan Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Pharma Grade Lentinan Market Size Markets, 2022 & 2029
4.1.2 Purity Below 98%
4.1.3 Purity Above 98%
4.2 By Type – Global Pharma Grade Lentinan Revenue & Forecasts
4.2.1 By Type – Global Pharma Grade Lentinan Revenue, 2018-2023
4.2.2 By Type – Global Pharma Grade Lentinan Revenue, 2024-2029
4.2.3 By Type – Global Pharma Grade Lentinan Revenue Market Share, 2018-2029
4.3 By Type – Global Pharma Grade Lentinan Sales & Forecasts
4.3.1 By Type – Global Pharma Grade Lentinan Sales, 2018-2023
4.3.2 By Type – Global Pharma Grade Lentinan Sales, 2024-2029
4.3.3 By Type – Global Pharma Grade Lentinan Sales Market Share, 2018-2029
4.4 By Type – Global Pharma Grade Lentinan Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Pharma Grade Lentinan Market Size, 2022 & 2029
5.1.2 Anti-Cancer Drug
5.1.3 Health Product Field
5.1.4 Others
5.2 By Application – Global Pharma Grade Lentinan Revenue & Forecasts
5.2.1 By Application – Global Pharma Grade Lentinan Revenue, 2018-2023
5.2.2 By Application – Global Pharma Grade Lentinan Revenue, 2024-2029
5.2.3 By Application – Global Pharma Grade Lentinan Revenue Market Share, 2018-2029
5.3 By Application – Global Pharma Grade Lentinan Sales & Forecasts
5.3.1 By Application – Global Pharma Grade Lentinan Sales, 2018-2023
5.3.2 By Application – Global Pharma Grade Lentinan Sales, 2024-2029
5.3.3 By Application – Global Pharma Grade Lentinan Sales Market Share, 2018-2029
5.4 By Application – Global Pharma Grade Lentinan Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Pharma Grade Lentinan Market Size, 2022 & 2029
6.2 By Region – Global Pharma Grade Lentinan Revenue & Forecasts
6.2.1 By Region – Global Pharma Grade Lentinan Revenue, 2018-2023
6.2.2 By Region – Global Pharma Grade Lentinan Revenue, 2024-2029
6.2.3 By Region – Global Pharma Grade Lentinan Revenue Market Share, 2018-2029
6.3 By Region – Global Pharma Grade Lentinan Sales & Forecasts
6.3.1 By Region – Global Pharma Grade Lentinan Sales, 2018-2023
6.3.2 By Region – Global Pharma Grade Lentinan Sales, 2024-2029
6.3.3 By Region – Global Pharma Grade Lentinan Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Pharma Grade Lentinan Revenue, 2018-2029
6.4.2 By Country – North America Pharma Grade Lentinan Sales, 2018-2029
6.4.3 US Pharma Grade Lentinan Market Size, 2018-2029
6.4.4 Canada Pharma Grade Lentinan Market Size, 2018-2029
6.4.5 Mexico Pharma Grade Lentinan Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Pharma Grade Lentinan Revenue, 2018-2029
6.5.2 By Country – Europe Pharma Grade Lentinan Sales, 2018-2029
6.5.3 Germany Pharma Grade Lentinan Market Size, 2018-2029
6.5.4 France Pharma Grade Lentinan Market Size, 2018-2029
6.5.5 U.K. Pharma Grade Lentinan Market Size, 2018-2029
6.5.6 Italy Pharma Grade Lentinan Market Size, 2018-2029
6.5.7 Russia Pharma Grade Lentinan Market Size, 2018-2029
6.5.8 Nordic Countries Pharma Grade Lentinan Market Size, 2018-2029
6.5.9 Benelux Pharma Grade Lentinan Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Pharma Grade Lentinan Revenue, 2018-2029
6.6.2 By Region – Asia Pharma Grade Lentinan Sales, 2018-2029
6.6.3 China Pharma Grade Lentinan Market Size, 2018-2029
6.6.4 Japan Pharma Grade Lentinan Market Size, 2018-2029
6.6.5 South Korea Pharma Grade Lentinan Market Size, 2018-2029
6.6.6 Southeast Asia Pharma Grade Lentinan Market Size, 2018-2029
6.6.7 India Pharma Grade Lentinan Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Pharma Grade Lentinan Revenue, 2018-2029
6.7.2 By Country – South America Pharma Grade Lentinan Sales, 2018-2029
6.7.3 Brazil Pharma Grade Lentinan Market Size, 2018-2029
6.7.4 Argentina Pharma Grade Lentinan Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Pharma Grade Lentinan Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Pharma Grade Lentinan Sales, 2018-2029
6.8.3 Turkey Pharma Grade Lentinan Market Size, 2018-2029
6.8.4 Israel Pharma Grade Lentinan Market Size, 2018-2029
6.8.5 Saudi Arabia Pharma Grade Lentinan Market Size, 2018-2029
6.8.6 UAE Pharma Grade Lentinan Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Ajinomoto
7.1.1 Ajinomoto Company Summary
7.1.2 Ajinomoto Business Overview
7.1.3 Ajinomoto Pharma Grade Lentinan Major Product Offerings
7.1.4 Ajinomoto Pharma Grade Lentinan Sales and Revenue in Global (2018-2023)
7.1.5 Ajinomoto Key News & Latest Developments
7.2 Nammex
7.2.1 Nammex Company Summary
7.2.2 Nammex Business Overview
7.2.3 Nammex Pharma Grade Lentinan Major Product Offerings
7.2.4 Nammex Pharma Grade Lentinan Sales and Revenue in Global (2018-2023)
7.2.5 Nammex Key News & Latest Developments
7.3 Xi’an Yuansun Biological
7.3.1 Xi’an Yuansun Biological Company Summary
7.3.2 Xi’an Yuansun Biological Business Overview
7.3.3 Xi’an Yuansun Biological Pharma Grade Lentinan Major Product Offerings
7.3.4 Xi’an Yuansun Biological Pharma Grade Lentinan Sales and Revenue in Global (2018-2023)
7.3.5 Xi’an Yuansun Biological Key News & Latest Developments
7.4 Golden Horizon Biologics
7.4.1 Golden Horizon Biologics Company Summary
7.4.2 Golden Horizon Biologics Business Overview
7.4.3 Golden Horizon Biologics Pharma Grade Lentinan Major Product Offerings
7.4.4 Golden Horizon Biologics Pharma Grade Lentinan Sales and Revenue in Global (2018-2023)
7.4.5 Golden Horizon Biologics Key News & Latest Developments
7.5 Acetar Bio-Tech
7.5.1 Acetar Bio-Tech Company Summary
7.5.2 Acetar Bio-Tech Business Overview
7.5.3 Acetar Bio-Tech Pharma Grade Lentinan Major Product Offerings
7.5.4 Acetar Bio-Tech Pharma Grade Lentinan Sales and Revenue in Global (2018-2023)
7.5.5 Acetar Bio-Tech Key News & Latest Developments
7.6 Johncan Mushroom Bio-technology
7.6.1 Johncan Mushroom Bio-technology Company Summary
7.6.2 Johncan Mushroom Bio-technology Business Overview
7.6.3 Johncan Mushroom Bio-technology Pharma Grade Lentinan Major Product Offerings
7.6.4 Johncan Mushroom Bio-technology Pharma Grade Lentinan Sales and Revenue in Global (2018-2023)
7.6.5 Johncan Mushroom Bio-technology Key News & Latest Developments
8 Global Pharma Grade Lentinan Production Capacity, Analysis
8.1 Global Pharma Grade Lentinan Production Capacity, 2018-2029
8.2 Pharma Grade Lentinan Production Capacity of Key Manufacturers in Global Market
8.3 Global Pharma Grade Lentinan Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Pharma Grade Lentinan Supply Chain Analysis
10.1 Pharma Grade Lentinan Industry Value Chain
10.2 Pharma Grade Lentinan Upstream Market
10.3 Pharma Grade Lentinan Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Pharma Grade Lentinan Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
世界の医薬品用レンチナン市場予測2023-2029：純度98%以下、純度98%以上 |
| 【英語タイトル】Pharma Grade Lentinan Market, Global Outlook and Forecast 2023-2029 | |
 | ・商品コード：MMG23JU2195 ・発行会社（調査会社）：Market Monitor Global ・発行日：2023年6月 ・ページ数：71 ・レポート言語：英語 ・レポート形式：PDF ・納品方法：Eメール（受注後2-3営業日） ・調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど ・産業分野：化学＆材料 |
| Single User（1名様閲覧用） | USD3,250 ⇒換算￥494,000 | 見積依頼/購入/質問フォーム |
| Multi User（20名様閲覧用） | USD4,225 ⇒換算￥642,200 | 見積依頼/購入/質問フォーム |
| Enterprise User（閲覧人数制限なし） | USD4,875 ⇒換算￥741,000 | 見積依頼/購入/質問フォーム |
|
※販売価格オプションの説明 ※お支払金額：換算金額（日本円）＋消費税 ※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡） ※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能） |
| 当調査レポートは次の情報を含め、世界の医薬品用レンチナン市場規模と予測を収録しています。・世界の医薬品用レンチナン市場：売上、2018年-2023年、2024年-2029年 ・世界の医薬品用レンチナン市場：販売量、2018年-2023年、2024年-2029年 ・世界のトップ5企業、2022年 世界の医薬品用レンチナン市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「純度98%以下」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。 医薬品用レンチナンのグローバル主要企業は、Ajinomoto、 Nammex、 Xi'an Yuansun Biological、 Golden Horizon Biologics、 Acetar Bio-Tech、 Johncan Mushroom Bio-technologyなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。 MARKET MONITOR GLOBAL（MMG）は、医薬品用レンチナンのメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。 【セグメント別市場分析】 世界の医薬品用レンチナン市場：タイプ別、2018年-2023年、2024年-2029年 世界の医薬品用レンチナン市場：タイプ別市場シェア、2022年 ・純度98%以下、純度98%以上 世界の医薬品用レンチナン市場：用途別、2018年-2023年、2024年-2029年 世界の医薬品用レンチナン市場：用途別市場シェア、2022年 ・抗がん剤、健康食品分野、その他 世界の医薬品用レンチナン市場：地域・国別、2018年-2023年、2024年-2029年 世界の医薬品用レンチナン市場：地域別市場シェア、2022年 ・北米：アメリカ、カナダ、メキシコ ・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア ・アジア：中国、日本、韓国、東南アジア、インド ・南米：ブラジル、アルゼンチン ・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE 【競合分析】 また、当レポートは主要な市場参加者の分析を提供します。 ・主要企業における医薬品用レンチナンのグローバル売上、2018年-2023年 ・主要企業における医薬品用レンチナンのグローバル売上シェア、2022年 ・主要企業における医薬品用レンチナンのグローバル販売量、2018年-2023年 ・主要企業における医薬品用レンチナンのグローバル販売量シェア、2022年 さらに、当レポートは主要企業のプロファイルを提示します。 Ajinomoto、 Nammex、 Xi'an Yuansun Biological、 Golden Horizon Biologics、 Acetar Bio-Tech、 Johncan Mushroom Bio-technology ************************************************************* ・調査・分析レポートの概要 医薬品用レンチナン市場の定義 市場セグメント 世界の医薬品用レンチナン市場概要 当レポートの特徴・ベネフィット 調査手法と情報源 ・世界の医薬品用レンチナン市場規模 世界の医薬品用レンチナン市場規模：2022年 VS 2029年 世界の医薬品用レンチナン市場規模と予測 2018年-2029年 ・競争状況 グローバルトップ企業 売上ベースでのグローバルトップ企業 企業別グローバルでの医薬品用レンチナンの売上 グローバルトップ3およびトップ5企業、2022年売上ベース グローバル企業の医薬品用レンチナン製品タイプ グローバルにおけるティア1、ティア2、ティア3企業 ・タイプ別市場分析 タイプ区分：純度98%以下、純度98%以上 医薬品用レンチナンのタイプ別グローバル売上・予測 ・用途別市場分析 用途区分：抗がん剤、健康食品分野、その他 医薬品用レンチナンの用途別グローバル売上・予測 ・地域別市場分析 地域別医薬品用レンチナン市場規模 2022年と2029年 地域別医薬品用レンチナン売上・予測 北米市場：アメリカ、カナダ、メキシコ ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア アジア市場：中国、日本、韓国、東南アジア、インド 南米市場：ブラジル、アルゼンチン 中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE ・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど） Ajinomoto、 Nammex、 Xi'an Yuansun Biological、 Golden Horizon Biologics、 Acetar Bio-Tech、 Johncan Mushroom Bio-technology ... |
Lentinan is a beta-glucan (a type of polysaccharide) from the mushroom lentinus edodes (shiitake mushroom). It has been studied in Japan as a treatment for cancer.
This report aims to provide a comprehensive presentation of the global market for Pharma Grade Lentinan, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pharma Grade Lentinan. This report contains market size and forecasts of Pharma Grade Lentinan in global, including the following market information:
Global Pharma Grade Lentinan Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Pharma Grade Lentinan Market Sales, 2018-2023, 2024-2029, (Tons)
Global top five Pharma Grade Lentinan companies in 2022 (%)
The global Pharma Grade Lentinan market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Purity Below 98% Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Pharma Grade Lentinan include Ajinomoto, Nammex, Xi’an Yuansun Biological, Golden Horizon Biologics, Acetar Bio-Tech and Johncan Mushroom Bio-technology, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Pharma Grade Lentinan manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Pharma Grade Lentinan Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (Tons)
Global Pharma Grade Lentinan Market Segment Percentages, by Type, 2022 (%)
Purity Below 98%
Purity Above 98%
Global Pharma Grade Lentinan Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (Tons)
Global Pharma Grade Lentinan Market Segment Percentages, by Application, 2022 (%)
Anti-Cancer Drug
Health Product Field
Others
Global Pharma Grade Lentinan Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (Tons)
Global Pharma Grade Lentinan Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Pharma Grade Lentinan revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Pharma Grade Lentinan revenues share in global market, 2022 (%)
Key companies Pharma Grade Lentinan sales in global market, 2018-2023 (Estimated), (Tons)
Key companies Pharma Grade Lentinan sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Ajinomoto
Nammex
Xi’an Yuansun Biological
Golden Horizon Biologics
Acetar Bio-Tech
Johncan Mushroom Bio-technology
Outline of Major Chapters:
Chapter 1: Introduces the definition of Pharma Grade Lentinan, market overview.
Chapter 2: Global Pharma Grade Lentinan market size in revenue and volume.
Chapter 3: Detailed analysis of Pharma Grade Lentinan manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Pharma Grade Lentinan in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Pharma Grade Lentinan capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
❖ レポートの目次 ❖
| ★調査レポート[世界の医薬品用レンチナン市場予測2023-2029：純度98%以下、純度98%以上] (コード：MMG23JU2195)販売に関する免責事項を必ずご確認ください。 |
| ★調査レポート[世界の医薬品用レンチナン市場予測2023-2029：純度98%以下、純度98%以上]についてメールでお問い合わせ |
